SCSergey Vladimirovich Chepanov

Sergey Vladimirovich Chepanov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sergey Vladimirovich Chepanov has a total of 122 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cross-Study Meta-Analysis of Blood Transcriptomes in Type 2 Diabetes

    by Aleksandr A. Tkachenko, Ziravard N. Tonyan, Yulia A. Nasykhova, Yury A. Barbitoff, Iaroslav N. Renev, Maria M. Danilova, Anastasiia A. Basipova, Olga B. Glavnova, Dmitrii E. Polev, Sergey V. Chepanov, et al.

    Type 2 diabetes (T2D) is a chronic metabolic disorder with an estimated prevalence of over 422 million individuals affected globally. Since the advent of genomics, numerous studies have been conducted to elucidate T2D pathogenetic mechanisms and define genetic loci affecting T2D susceptibility. Transcriptomic studies, including bulk and single-cell RNA sequencing, play an important role both in discerning molecular mechanisms of the disease and in identifying potential T2D biomarkers. In this study, we performed bulk RNA-seq of whole blood of nine T2D patients and nine control subjects and performed meta-analysis of these data with seven publicly available blood RNA-seq datasets of T2D patients. Our analysis showed that the changes in the gene expression between different studies show very low concordance; moreover, a substantial number of differentially expressed genes (DEGs) was identified in only three out of eight datasets, with only five DEGs—FBLN2, TPCN1, PC, SHANK1, and PLD4—identified in all three of those datasets. Nevertheless, cross-study meta-analysis identified a broad set of 2065 DEGs, including 713 genes that have not been identified in any of the source studies. These genes showed a significant enrichment of GO terms indicating neutrophil activation and proliferation and included several genes that have not been implicated in type 2 diabetes previously. Taken together, our study highlights challenges associated with biomarker discovery from blood transcriptomics in T2D and suggests novel genes that may be considered as such biomarkers.


  • The effect of progesterone treatment on natural killer cell functional activity and progesterone-induced blocking factor secretion in pregnant women with a history of recurrent pregnancy loss

    by Alina A. Davydova, Valentina A. Mikhailova, Sergey V. Chepanov, Maria S. Zementova, Elena I. Abashova, Elena V. Misharina, Margarita O. Shengelia, Anna A. Olina, Maria I. Yarmolinskaya, Olesya N. Bespalova, et al.

    BACKGROUND: Progesterone is a steroid hormone that plays a crucial role in regulating reproductive processes in women. Its decreased secretion can increase the risk of miscarriage. Progesterone-induced blocking factor is a protein that acts as a mediator of progesterone’s effects. In cases of spontaneous miscarriages, the serum concentration of this protein is lower than during normal pregnancies. It is believed that progesterone-induced blocking factor may affect the functional activity of natural killer cells, which are essential for early pregnancy development. However, studies that thoroughly evaluate the effects of different forms of progesterone on natural killer cell functional activity in reproductive failure are lacking. AIM: The aim of this study was to evaluate the effects of micronized progesterone and dydrogesterone on the functional activity of natural killer cells and progesterone-induced blocking factor levels in pregnant women with a history of recurrent pregnancy loss. METHODS: The levels of progesterone and progesterone-induced blocking factor were measured in the peripheral blood serum of pregnant women with a history of miscarriage who received micronized progesterone (group 1) or dydrogesterone (group 2). We also assessed the content of natural killer cells in the peripheral blood, their functional activity as measured by the CD107a degranulation marker, and their cytotoxic activity against JEG-3 trophoblast cells. The parameters were measured twice: at 8–10 weeks (first visit) and 13–15 weeks (second visit). RESULTS: At the first visit, group 1 showed lower cytotoxicity of natural killer cells compared to group 2 (p = 0.018). Both groups showed an increase in progesterone levels at the second visit compared to the first visit. Against the background of micronized progesterone administration, we observed an increase in PC-induced activated CD107a+ natural killer cells (p = 0.019). At the second visit, a negative correlation was found in group 1 between progesterone levels and the cytotoxic effect of natural killer cells on trophoblast cells (r = −0.94, p = 0.008). A similar correlation was found in group 2 between progesterone levels and the content of PC-induced activated CD107a+(i) natural killer cells (r = −0.724, p = 0.044). We observed no changes in the blood serum concentration of progesterone-induced blocking factor in the study groups. CONCLUSION: The effects of micronized progesterone and dydrogesterone preparations on the functional activity of natural killer cells in pregnant women with a history of recurrent pregnancy loss have been established. Research into the effects of progesterone preparations on production of pregnancy-induced blocking factor and the functional activity of natural killer cells could lead to the pathologically justified use of this type of treatment to prevent miscarriage in women with recurrent pregnancy loss.

  • Open Access

    Determination of cytokine and growth factor levels to assess endothelial dysfunction in reproductive pathologies

    by S. V. Chepanov, A. A. Sirotskaya, D. I. Sokolov, O. N. Bespalova, V. N. Babakov, N. Yu. Rogovskaya, E. S. Orlova, С. А. Сельков, Н. Ю. Роговская

    Our objective was to evaluate the level of cytokines and growth factors in peripheral blood in women with pregnancy failure, including women with detectable antiphospholipid antibodies (APhA). Eighty-eight women aged 22 to 45 years were examined. The patients were divided into groups: control group included women with physiologically normal pregnancy; the main group consisted of women with a history of one or more cases of miscarriage. The main group was subdivided into subgroups depending on the presence or absence of APhA in blood serum. The APhA-positive subgroup and a history of miscarriage was then subdivided into subgroups with high and low levels as measured by ELISA test. We evaluated the levels of antibodies to cardiolipin and beta2-glycoprotein-I, and the concentrations of cytokines (IL-1b, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12(p70), IL-13, IL-15, IL-17, Eotaxin, bFGF, G-CSF, GM-CSF, IFNg, IP-10, MCP-1 (MCAF), MIP-1a, PDGF-BB, MIP-1b, RANTES, TNFa, VEGF) in their blood serum and plasma samples. Women with a history of miscarriage, either negative or positive for APhA, are at risk, having an increased contents of proinflammatory cytokines in peripheral blood. Moreover, the women with APhA and a history of miscarriage comprise a group at risk for developing preeclampsia, having increased VEGF, IL-6 and IL-8 levels in peripheral blood. AFAs, regardless of their level, may contribute to development of the pathological process, since an imbalance of proand anti-inflammatory cytokines has been shown in women with APhA, due to a decrease in compensatory anti-inflammatory response. Women with a history of miscarriage and AFAs are more susceptible to placental disorders. Determination of a complex of immunological markers enabled us to clarify various pathophysiological pathways of obstetric pathology, including miscarriage of pregnancy. In this regard, the promising approach would be a search for the most significant combinations of proand anti-inflammatory cytokines, growth-promoting and angiogenic factors with both positive and negative regulation.

  • Open Access

    Deciphering the Transcriptomic Landscape of Type 2 Diabetes: Insights from Bulk RNA Sequencing and Single-Cell Analysis

    by Alexander A. Tkachenko, Ziravard N. Tonyan, Yulia A. Nasykhova, Yury A. Barbitoff, Iaroslav N. Renev, Maria M. Danilova, Anastasiia A. Mikhailova, Olga B. Glavnova, Sergey V. Chepanov, Sergey A. Selkov, et al.

    Type 2 diabetes (T2D) is a chronic metabolic disorder marked by insulin resistance and relative insulin deficiency, affecting over 422 million people globally and projected to increase, making it a major public health concern. This condition is associated with severe complications such as retinopathy, nephropathy, cardiovascular diseases, and neuropathy, highlighting the need for a deeper understanding of its mechanisms to develop more effective prevention and treatment strategies. Transcriptomic analysis, particularly through RNA-seq, has provided valuable insights into the gene expression patterns in T2D, highlighting pathways involved in insulin signaling, metabolic regulation, and inflammation. This approach, including single-cell RNA sequencing, helps overcome the challenges of immune cell population heterogeneity, enabling the identification of distinct cell types and their specific roles in T2D progression. In this paper, we present a dataset of single-cell and bulk RNA sequencing results comparing expression patterns in blood cells between diabetes and healthy samples and describe some preliminary analysis of the dataset, highlighting differences in both gene expression and cell type composition and putting them in the context of existing research of T2D.

  • Open Access

    Targeted Gene Delivery to Muscle Cells In Vitro and In Vivo Using Electrostatically Stabilized DNA—Peptide Complexes

    by Anna Egorova, Sergei Chepanov, Sergei Selkov, Igor Kogan, Anton Kiselev

    Genetic constructs must be delivered selectively to target tissues and intracellular compartments at the necessary concentrations in order to achieve the maximum therapeutic effect in gene therapy. Development of targeted carriers for non-viral delivery of nucleic acids into cells, including those in muscle, which is one of the most challenging tissues to transfect in vivo, remains a topical issue. We have studied ternary complexes of plasmid DNA and an arginine–histidine-rich peptide-based carrier coated with a glutamate–histidine-rich polymer bearing skeletal muscle targeting peptide (SMTP) for the gene delivery to muscle tissue. The relaxation of the ternary complexes after polyanion treatment was assessed using the ethidium bromide displacement assay. The developed polyplexes were used to transfect C2C12 myoblasts in full-media conditions, followed by analysis of their toxic properties using the Alamar Blue assay and expression analysis of lacZ and GFP reporter genes. After delivering plasmids containing the GFP and lacZ genes into the femoral muscles of mdx mice, which are model of Duchenne muscular dystrophy, GFP fluorescence and β-galactosidase activity were detected. We observed that the modification of ternary polyplexes with 10 mol% of SMTP ligand resulted in a 2.3-fold increase in lacZ gene expression when compared to unmodified control polyplexes in vivo. Thus, we have demonstrated that the developed DNA/carrier complexes and SMTP-modified coating are nontoxic, are stable against polyanion-induced relaxation, and can provide targeted gene delivery to muscle cells and tissues. The results of this study are useful for a range of therapeutic applications, from immunization to amelioration of inherited neuromuscular diseases.


  • Open Access

    Исследование пептидного состава и идентификация пептида с противовоспалительными и антиагрегантными свойствами в экстракте простаты крупного рогатого скота

    by Сергей Александрович Савельев, Алексей Георгиевич Миттенберг, Татьяна Игоревна Арефьева, Татьяна Ивановна Опарина, Сергей Владимирович Чепанов

    В статье описана попытка идентификации пептидного состава экстракта простаты крупного рогатого скота, произведённого по технологии водно-уксусной экстракции с последующей тангенциальной ультрафильтрацией. Обнаружены белково-пептидные компоненты с известной функциональной активностью. Среди найденных фрагментов регуляторных белков был отобран, синтезирован и протестирован в трех биологических моделях новый, не описанный ранее пептид, являющийся фрагментом бычьего хемокина МСР-1. Показана способность пептида in vitro подавлять миграцию моноцитарных клеток и агрегацию тромбоцитов. По результатам проведенного анализа найденный пептидный фрагмент оценен как перспективный для создания синтетического аналога экстракта простаты, а также для терапии заболеваний аутоиммунной и псевдоаллергенной природы.


  • Clinical and immunological criteria for the use of intravenous immunoglobulins in women with reproductive failures

    by Alana O. Agnaeva, Olesya N. Bespalova, Dmitry I. Sokolov, Valentina A. Mikhailova, Sergey V. Chepanov, Sergey A. Selkov, Igor Yu. Kogan

    BACKGROUND:In obstetrics and reproductive medicine, the use of intravenous immunoglobulin remains controversial. There are no clearly developed indications for immunoglobulins therapy. The search for immunological criteria for prescribing this therapy is an urgent task AIM:The aim of this study was to evaluate the effectiveness of the use of intravenous immunoglobulins in the complex therapy of women with multiple reproductive losses associated with changes in the quantitative and functional parameters of natural killer cells. MATERIALS AND METHODS:Group 1 consisted of 61 women with recurrent miscarriage; group 2 involved 40 women with two or morein vitrofertilization failures, while group 3 comprised 27 healthy fertile individuals. The activity of blood natural killer cells was assessed by CD107a expression before and after activation. Patients with altered natural killer cell activity received intravenous immunoglobulins therapy under the control of the dynamics of immunological parameters. RESULTS:The number of natural killer cells that expressed CD107a before and after activation differed between the study groups. In patients receiving intravenous immunoglobulins, gestational complications were observed less frequently, with the incidence of biochemical pregnancy being higher. CONCLUSIONS:In patients with early reproductive failures (such as recurrent miscarriage andin vitrofertilization failures) and immunological abnormalities in the form of altered Natural killer cell activity, the use of intravenous immunoglobulins has an immunomodulatory and clinical effect.

  • Autosensitization to human chorionic gonadotropin: etiology, role in reproductive loss, and approaches to therapy

    by Daria V. Tkhai, Sergey V. Chepanov, Olga N. Arzhanova, Olesya N. Bespalova, Sergey A. Selkov, Тхай Дарья Валерьевна

    The important role of human chorionic gonadotropin in pregnancy suggests the occurrence of reproductive disorders due to the circulation of specific antibodies, especially in early pregnancy, which can lead to a cascade of pathological reactions such as implantation failure, placentation, trophoblast invasion, and ultimately fetal rejection. The lack of knowledge and the complexity of diagnosing and treating this autoimmune pathology in reproductive medicine and obstetrics negatively affects both the outcomes of each individual pregnancy and the demographic situation as a whole. This review article highlights the main ideas about the causes of human chorionic gonadotropin antibody occurrence, the pathological mechanisms, the reproductive and obstetric complications associated with human chorionic gonadotropin autoantibodies, diagnostic methods, and therapeutic approaches.

  • Biological profile of the follicular fluid. A pilot study

    by Olesya N. Bespalova, Margarita O. Shengelia, Valeriya A. Zagaynova, Sergey V. Chepanov, Evgeniia M. Komarova, Igor Yu. Kogan

    BACKGROUND: One of the most important research areas in the field of reproductive medicine is the search for biochemical and immunological parameters of oocyte quality and predicting the effectiveness of assisted reproductive technology protocols. AIM: The aim of this study was to evaluate the expression of follicular fluid soluble human leukocyte antigen-G, human leukocyte antigen-E, human leukocyte antigen-C, progesterone-inducing blocking factor, and relaxin levels in women with reproductive disorders. MATERIALS AND METHODS: This prospective cohort study included 22 patients undergoing infertility treatment in a superovulation stimulation protocol using gonadotropin-releasing hormone antagonists. The inclusion criteria were age from 25 to 39 years, tubal-peritoneal factor infertility, and voluntary participation informed consent. The levels of soluble human leukocyte antigen-G, human leukocyte antigen-E, human leukocyte antigen-C, progesterone-inducing blocking factor, and relaxin in follicular fluid samples were determined on the day of transvaginal follicle puncture by enzyme immunoassay. RESULTS: We established an inverse correlation between the expression levels of progesterone-inducing blocking factor and relaxin (r = 0.450) in the follicular fluid, antibodies to thyroperoxidase (r = 0.649), and thyroid-stimulating hormone (r = 0.519). We also found a direct correlation between human leukocyte antigen-E parameters in the follicular fluid, age (r = 0.813) and Body Mass Index (r = 0.866), as well as between human leukocyte antigen-C expression levels and total testosterone (r = 0.960). No data were obtained on any significant correlations between the studied biomarkers and the number of received oocytes. CONCLUSIONS: In this comprehensive study, we were the first who found the expression levels of five different follicular fluid components, namely, soluble human leukocyte antigen-G, human leukocyte antigen-E, human leukocyte antigen-C, progesterone-inducing blocking factor, and relaxin. Such a complex assessment of the follicular fluid can allow for establishing the quality of the oocyte to predict the onset of pregnancy in an in vitro fertilization protocol.


  • Prognostic value of anti- and proangiogenic factors in severe preeclampsia

    by Margarita Yu. Vasileva, Ilya V. Smirnov, Valentina V. Ishkaraeva, Natalya Yu. Yakovleva, Elena Yu. Vasilyeva, Sergey V. Chepanov, Lyudmila V. Kalosha, Olga N. Tamakhina, Sergey A. Selkov, Irina E. Zazerskaya, et al.

    BACKGROUND:Over the years, preeclampsia has remained a common pathology of pregnancy. Its severe form poses a significant threat to the health of the woman and the fetus. To assess the risk of developing preeclampsia, biochemical screening for placental growth factor and soluble tyrosine kinase-1 is carried out. The soluble glycoprotein endoglin, which regulates angiogenesis by influencing cell activation, adhesion, and migration, can supplement the idea of the imbalance of vascular factors in severe preeclampsia. A holistic study of anti- and proangiogenic factors can significantly complement the diagnosis of preeclampsia at the preclinical stage and a look at the course and treatment of this pregnancy complication. AIM:The aim of this work was to evaluate the concentrations of anti- and proangiogenic factors (soluble glycoprotein endoglin, soluble tyrosine kinase-1, placental growth factor) and compare the obtained data with the clinical manifestations of severe preeclampsia. MATERIALS AND METHODS:This case-control study included 81 pregnant women. The main group consisted of patients with severe preeclampsia (n= 41), while the control group comprised individuals with normal pregnancy (n= 40). To determine soluble glycoprotein endoglin levels in biological fluids, we used a new ELISA kit developed in the Laboratory of Hybridoma Technology, Academician A.M. Granov Russian Research Center for Radiology and Surgical Technologies (Saint Petersburg, Russia). placental growth factor and soluble tyrosine kinase-1 concentrations were assessed by electrochemiluminescence immunoassay using commercial Roche Diagnostics kits. Statistical analysis was performed using the StatTech v.3.0.6 program (Stattech Ltd., Russia). RESULTS:When analyzing the concentrations of anti- and proangiogenic factors (soluble glycoprotein endoglin in the blood serum and urine, soluble tyrosine kinase-1, placental growth factor and the ratio of these factors), depending on the study group, statistically significant results were obtained (p 0.05). The diagnostic significance of serum and urine soluble glycoprotein endoglin levels in predicting the probability of severe preeclampsia was assessed by the method of ROC curve analysis. Statistically significant differences (p 0.05) were found in the analysis of the concentrations of anti- and pro-angiogenic factors depending on the clinical manifestations such as systolic blood pressure 160 mm Hg (except for placental growth factor level), a multiple increase in urine soluble glycoprotein endoglin level with massive proteinuria, an increase in soluble glycoprotein endoglin levels in biological fluids with an increase in edematous syndrome. Correlation analysis revealed a significant relationship between anti- and proangiogenic factors and the term of delivery, as well as urine soluble glycoprotein endoglin level and the duration of the treatment. CONCLUSIONS:The data obtained complement the concept of severe preeclampsia. Knowing the concentrations of soluble glycoprotein endoglin in the blood serum and urine allows for predicting the timing of delivery and the possible duration of treatment, which is critical in the management of patients with severe preeclampsia.